Perfluorocarbon nanoemulsions with fluorescent, colloidal and magnetic properties. Janjic JM, Shao P, Zhang S, Yang X, Patel SK, Bai M (2014) Biomaterials 35: 4958-68 Frictional properties of mixed fluorocarbon/hydrocarbon silane monolayers: a simulation study. Lewis JB, Vilt SG, Rivera JL, Jennings GK, McCabe C (2012) Langmuir 28: 14218-26 Association between plasma PFOA and PFOS levels and total cholesterol in a middle-aged Danish population. Eriksen KT, Raaschou-Nielsen O, McLaughlin JK, Lipworth L, Tjønneland A, Overvad K, Sørensen M (2013) PLoS One 8: e56969 Imaging oxygen tension in liver and spleen by 19F NMR. Holland SK, Kennan RP, Schaub MM, D'Angelo MJ, Gore JC (1993) Magn Reson Med 29: 446-58 Prenatal exposure to PFOA and PFOS and risk of hospitalization for infectious diseases in early childhood. Fei C, McLaughlin JK, Lipworth L, Olsen J (2010) Environ Res 110: 773-7 Advances in sonographic detection of ovarian cancer: depiction of tumor neovascularity with microbubbles. Fleischer AC, Lyshchik A, Andreotti RF, Hwang M, Jones HW, Fishman DA (2010) AJR Am J Roentgenol 194: 343-8 A microfluidic cell co-culture platform with a liquid fluorocarbon separator. Brewer BM, Shi M, Edd JF, Webb DJ, Li D (2014) Biomed Microdevices 16: 311-23 Simultaneous grayscale and subharmonic ultrasound imaging on a modified commercial scanner. Eisenbrey JR, Dave JK, Halldorsdottir VG, Merton DA, Machado P, Liu JB, Miller C, Gonzalez JM, Park S, Dianis S, Chalek CL, Thomenius KE, Brown DB, Navarro V, Forsberg F (2011) Ultrasonics 51: 890-7 Contrast-Enhanced Subharmonic and Harmonic Ultrasound of Renal Masses Undergoing Percutaneous Cryoablation. Eisenbrey JR, Shaw CM, Lyshchik A, Machado P, Lallas CD, Trabulsi EJ, Merton DA, Fox TB, Liu JB, Brown DB, Forsberg F (2015) Acad Radiol 22: 820-6 A Pilot Clinical Study in Characterization of Malignant Renal-cell Carcinoma Subtype with Contrast-enhanced Ultrasound. Kasoji SK, Chang EH, Mullin LB, Chong WK, Rathmell WK, Dayton PA (2017) Ultrason Imaging 39: 126-136 Contrast-enhanced transvaginal sonography of benign versus malignant ovarian masses: preliminary findings. Fleischer AC, Lyshchik A, Jones HW, Crispens M, Loveless M, Andreotti RF, Williams PK, Fishman DA (2008) J Ultrasound Med 27: 1011-8; quiz 1019-21 Diagnostic parameters to differentiate benign from malignant ovarian masses with contrast-enhanced transvaginal sonography. Fleischer AC, Lyshchik A, Jones HW, Crispens MA, Andreotti RF, Williams PK, Fishman DA (2009) J Ultrasound Med 28: 1273-80 Measuring tumor perfusion in control and treated murine tumors: correlation of microbubble contrast-enhanced sonography to dynamic contrast-enhanced magnetic resonance imaging and fluorodeoxyglucose positron emission tomography. Niermann KJ, Fleischer AC, Huamani J, Yankeelov TE, Kim DW, Wilson WD, Hallahan DE (2007) J Ultrasound Med 26: 749-56 Quantification of tumor vascularity with contrast-enhanced sonography: correlation with magnetic resonance imaging and fluorodeoxyglucose autoradiography in an implanted tumor. Fleischer AC, Donnelly EF, Grippo RJ, Black AS, Hallahan DE (2004) J Ultrasound Med 23: 37-41
Hints: (1) double-click or double-tap to navigate to a node. (2) Grab a node and move it to arrange the graph.